Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
This review discusses the most recent evidence for currently available risk stratification tools in the detection of clinically significant prostate cancer (csPCa), and evaluates diagnostic strategies that combine these tools. Novel blood biomarkers, such as the Prostate Health Index (PHI) and 4Ksco...
Main Authors: | Daniël F. Osses, Monique J. Roobol, Ivo G. Schoots |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/7/1637 |
Similar Items
-
Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
by: Daniël F. Osses, et al.
Published: (2020-12-01) -
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
by: Brecht Chys, et al.
Published: (2020-03-01) -
Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification
by: Petter Davik, et al.
Published: (2022-09-01) -
Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports
by: Pieter Minnee, et al.
Published: (2019-11-01) -
The Use of MRI-Derived Radiomic Models in Prostate Cancer Risk Stratification: A Critical Review of Contemporary Literature
by: Linda My Huynh, et al.
Published: (2023-03-01)